CL2008003133A1 - Uso de albumina humana para la preparacion de un medicamento para el tratamiento de desordenes cognitivos en pacientes de alzheimer, donde el medicamento se encuentra en forma de solucion para recambio plasmatico y/o perfusion intravenosa. - Google Patents
Uso de albumina humana para la preparacion de un medicamento para el tratamiento de desordenes cognitivos en pacientes de alzheimer, donde el medicamento se encuentra en forma de solucion para recambio plasmatico y/o perfusion intravenosa.Info
- Publication number
- CL2008003133A1 CL2008003133A1 CL2008003133A CL2008003133A CL2008003133A1 CL 2008003133 A1 CL2008003133 A1 CL 2008003133A1 CL 2008003133 A CL2008003133 A CL 2008003133A CL 2008003133 A CL2008003133 A CL 2008003133A CL 2008003133 A1 CL2008003133 A1 CL 2008003133A1
- Authority
- CL
- Chile
- Prior art keywords
- drug
- alzheimer
- patients
- preparation
- treatment
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 3
- 102000008100 Human Serum Albumin Human genes 0.000 title abstract 2
- 108091006905 Human Serum Albumin Proteins 0.000 title abstract 2
- 208000010877 cognitive disease Diseases 0.000 title abstract 2
- 238000001802 infusion Methods 0.000 title 1
- 238000001990 intravenous administration Methods 0.000 title 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 230000010412 perfusion Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
USO DE ALBÚMINA HUMANA PARA LA PREPARACIÓN DE UN MEDICAMENTO PARA EL TRATAMIENTO DE DESÓRDENES COGNITIVOS EN PACIENTES CON ALZHEIMER SIN DEPENDENCIA DEL CONTENIDO DE AB EN SANGRE DEL PACIENTE DONDE EL MEDICAMENTO SE ENCUENTRA EN FORMA DE SOLUCIÓN PARA RECAMBIO PLASMÁTICO Y/O PERFUSIÓN INTRAVENOSA EN QUE LA ALBÚMINA ESTÁ INICIALINENTE A UNA CONCENTRACIÓN COMPRENDIDA ENTRE EL 4% (P/V) Y 25% (P/V).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200702831A ES2332846B1 (es) | 2007-10-26 | 2007-10-26 | Utilizacion de albumina humana terapeutica para la preparacion de un medicamento para el tratamiento de pacientes afectados por desordenes cognitivos. |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2008003133A1 true CL2008003133A1 (es) | 2009-08-07 |
Family
ID=40583637
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2008003133A CL2008003133A1 (es) | 2007-10-26 | 2008-10-23 | Uso de albumina humana para la preparacion de un medicamento para el tratamiento de desordenes cognitivos en pacientes de alzheimer, donde el medicamento se encuentra en forma de solucion para recambio plasmatico y/o perfusion intravenosa. |
Country Status (17)
Country | Link |
---|---|
US (1) | US7851446B2 (es) |
EP (1) | EP2111868B1 (es) |
JP (1) | JP5437619B2 (es) |
CN (1) | CN101417123B (es) |
AR (1) | AR068901A1 (es) |
AU (1) | AU2008233025B8 (es) |
BR (1) | BRPI0804623B8 (es) |
CA (1) | CA2641830C (es) |
CL (1) | CL2008003133A1 (es) |
ES (2) | ES2332846B1 (es) |
HK (1) | HK1126689A1 (es) |
MX (1) | MX2008013635A (es) |
NZ (1) | NZ572131A (es) |
PL (1) | PL2111868T3 (es) |
PT (1) | PT2111868E (es) |
RU (1) | RU2414925C2 (es) |
UY (1) | UY31418A1 (es) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2802628C2 (ru) * | 2018-10-25 | 2023-08-30 | Грифольс Уорлдуайд Оперейшнс Лимитед | Использование плазмафереза малого объема для лечения болезни альцгеймера на ранних и средних стадиях |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5843345B2 (ja) | 2010-07-08 | 2016-01-13 | 旭化成メディカル株式会社 | β−アミロイド除去システム |
PL3484502T3 (pl) * | 2016-08-18 | 2022-01-31 | Alkahest, Inc. | Frakcje osocza krwi jako terapia związanych ze starzeniem zaburzeń funkcji poznawczych |
EA039316B1 (ru) * | 2016-10-24 | 2022-01-12 | Алкахест, Инк. | Фракции плазмы крови в качестве лечения когнитивных расстройств, связанных со старением |
DK3615057T3 (da) * | 2017-04-26 | 2024-01-02 | Alkahest Inc | Doseringsskema til behandling af kognitive svækkelser med blodplasmaprodukter |
US11040068B2 (en) | 2017-04-26 | 2021-06-22 | Alkahest, Inc. | Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products |
EP4374921A3 (en) * | 2018-07-20 | 2024-06-19 | Alkahest, Inc. | Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products |
EP3643319A1 (en) * | 2018-10-25 | 2020-04-29 | Grifols Worldwide Operations Limited | Use of low volume plasma exchange for the treatment of alzheimer's disease in early and middle stages |
JP7504090B2 (ja) | 2018-10-26 | 2024-06-21 | アルカヘスト,インコーポレイテッド | 疼痛、創傷治癒及び術後回復の改善のための血漿及び血漿画分の使用 |
AU2021372848A1 (en) * | 2020-10-30 | 2023-06-22 | Shenzhen Protgen Ltd. | Use of human serum albumin in treatment of diseases |
WO2022229705A1 (es) * | 2021-04-30 | 2022-11-03 | Grifols Worldwide Operations Limited | Uso de recambio plasmático terapéutico y recambio plasmático de bajo volumen para el tratamiento de un deterioro cognitivo |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3612137A1 (de) | 1986-04-10 | 1987-10-15 | Biotest Pharma Gmbh | Steriles plasmaaustauschmittel |
US5112298A (en) | 1990-06-25 | 1992-05-12 | Baxter International Inc. | Apheresis method and device |
US5178603A (en) | 1990-07-24 | 1993-01-12 | Baxter International, Inc. | Blood extraction and reinfusion flow control system and method |
US6627151B1 (en) * | 1997-06-13 | 2003-09-30 | Helmut Borberg | Method for treatment diseases associated with a deterioration of the macrocirculation, microcirculation and organ perfusion |
ATE312354T1 (de) | 2000-05-23 | 2005-12-15 | Univ Southern California | Diagnose von alzheimerkrankheit unter verwendung von ldl-rezeptor-protein-1 |
EP1370240A4 (en) * | 2001-03-02 | 2004-09-22 | Neuron Therapeutics Inc | NEUROPROTECTOR FORMULATIONS AND METHOD |
WO2003051374A2 (en) | 2001-12-17 | 2003-06-26 | New York State Office Of Mental Health | SEQUESTRATION OF Aβ IN THE PERIPHERY IN THE ABSENCE OF IMMUNOMODULATING AGENT AS A THERAPEUTIC APPROACH FOR THE TREATMENT OR PREVENTION OF BETA-AMYLOID RELATED DISEASES |
EP2210892A3 (en) | 2002-10-04 | 2010-10-27 | Prana Biotechnology Limited | Neurologically-active compounds |
AU2003303198A1 (en) | 2002-12-19 | 2004-07-14 | New York University | Method for treating amyloid disease |
UA80469C2 (en) | 2003-02-13 | 2007-09-25 | Octapharma Ag | Method for the production of albumin |
AU2004311577A1 (en) | 2003-07-11 | 2005-07-21 | Myriad Genetics, Inc. | Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease |
AT413336B (de) * | 2003-09-12 | 2006-02-15 | Mattner Frank Dr | Apherese-vorrichtung |
US20050182044A1 (en) | 2004-02-17 | 2005-08-18 | Bruinsma Gosse B. | Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate |
AT500483B1 (de) | 2004-07-13 | 2006-01-15 | Mattner Frank Dr | Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung |
US7436304B1 (en) | 2005-07-19 | 2008-10-14 | Visible Assets, Inc | Evidence tracking |
-
2007
- 2007-10-26 ES ES200702831A patent/ES2332846B1/es not_active Expired - Fee Related
-
2008
- 2008-10-17 NZ NZ572131A patent/NZ572131A/en unknown
- 2008-10-17 AR ARP080104523A patent/AR068901A1/es unknown
- 2008-10-17 RU RU2008141076/15A patent/RU2414925C2/ru active
- 2008-10-22 PL PL08380301T patent/PL2111868T3/pl unknown
- 2008-10-22 EP EP08380301.5A patent/EP2111868B1/en active Active
- 2008-10-22 PT PT83803015T patent/PT2111868E/pt unknown
- 2008-10-22 ES ES08380301T patent/ES2428698T3/es active Active
- 2008-10-23 BR BRPI0804623A patent/BRPI0804623B8/pt active IP Right Grant
- 2008-10-23 UY UY31418A patent/UY31418A1/es not_active Application Discontinuation
- 2008-10-23 CN CN2008101705786A patent/CN101417123B/zh active Active
- 2008-10-23 CL CL2008003133A patent/CL2008003133A1/es unknown
- 2008-10-23 MX MX2008013635A patent/MX2008013635A/es active IP Right Grant
- 2008-10-24 CA CA2641830A patent/CA2641830C/en active Active
- 2008-10-24 AU AU2008233025A patent/AU2008233025B8/en active Active
- 2008-10-24 JP JP2008274076A patent/JP5437619B2/ja active Active
- 2008-10-24 US US12/257,814 patent/US7851446B2/en active Active
-
2009
- 2009-07-02 HK HK09105923.2A patent/HK1126689A1/xx unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2802628C2 (ru) * | 2018-10-25 | 2023-08-30 | Грифольс Уорлдуайд Оперейшнс Лимитед | Использование плазмафереза малого объема для лечения болезни альцгеймера на ранних и средних стадиях |
Also Published As
Publication number | Publication date |
---|---|
EP2111868A1 (en) | 2009-10-28 |
HK1126689A1 (en) | 2009-09-11 |
BRPI0804623A2 (pt) | 2009-06-30 |
BRPI0804623B8 (pt) | 2021-05-25 |
RU2008141076A (ru) | 2010-04-27 |
JP2009108059A (ja) | 2009-05-21 |
JP5437619B2 (ja) | 2014-03-12 |
NZ572131A (en) | 2010-06-25 |
PT2111868E (pt) | 2013-10-17 |
US7851446B2 (en) | 2010-12-14 |
CN101417123A (zh) | 2009-04-29 |
BRPI0804623B1 (pt) | 2020-02-11 |
CA2641830A1 (en) | 2009-04-26 |
CN101417123B (zh) | 2012-06-27 |
MX2008013635A (es) | 2009-05-11 |
CA2641830C (en) | 2013-07-16 |
UY31418A1 (es) | 2009-05-29 |
US20090111740A1 (en) | 2009-04-30 |
AR068901A1 (es) | 2009-12-16 |
EP2111868B1 (en) | 2013-08-21 |
AU2008233025B2 (en) | 2013-06-27 |
PL2111868T3 (pl) | 2014-01-31 |
ES2428698T3 (es) | 2013-11-08 |
RU2414925C2 (ru) | 2011-03-27 |
ES2332846A1 (es) | 2010-02-12 |
AU2008233025B8 (en) | 2013-07-25 |
ES2332846B1 (es) | 2010-07-08 |
AU2008233025A1 (en) | 2009-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2008003133A1 (es) | Uso de albumina humana para la preparacion de un medicamento para el tratamiento de desordenes cognitivos en pacientes de alzheimer, donde el medicamento se encuentra en forma de solucion para recambio plasmatico y/o perfusion intravenosa. | |
AR084816A1 (es) | Metodos y medicamentos para el tratamiento de la enfermedad de alzheimer | |
AR111572A2 (es) | Formas farmacéuticas que contienen vardenafilo | |
TR201818927T4 (tr) | Kataterlerde İyileştirme | |
WO2007108987A3 (en) | Infusion device pump | |
AR099078A2 (es) | Un medicamento que comprende acetato de glatiramer | |
ECSP056076A (es) | Sistema de suministro para droga y terapia celular | |
AR054249A1 (es) | Tratamiento de enfermedades del tejido conectivo de la piel | |
BR0317450A (pt) | Fluidos de diálise biocompatìveis contendo icodextrinas | |
AR086356A1 (es) | Combinacion farmaceutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2 | |
BRPI0411032A (pt) | composição adesiva hidrófila, artigo médico, método para a fabricação da composição adesiva, e, dispositivo de administração transdérmica | |
TW200628182A (en) | Injection device for administering a medication liquid | |
JP2013541583A5 (es) | ||
AR048318A1 (es) | Formulaciones de matriz orales que comprenden licarbazepina | |
ECSP077843A (es) | Tratamiento o prevención del prurito | |
CY1116171T1 (el) | Χρηση ακετυλο-l-καρνιτινης για την παρασκευη φαρμακου για τη θεραπευτικη αγωγη του νευροπαθητικου πονου σε διαβητικους ασθενεις | |
MY174442A (en) | Treating critically ill patients with intravenous ibuprofen | |
AR047154A1 (es) | Tratamiento del insomnio en pacientes humanos administrandoles una cantidad diaria de gaboxadol | |
CN201441679U (zh) | 走动式输液架 | |
Club et al. | Autism Spectrum Disorders | |
CN202314371U (zh) | 输液避光瓶套 | |
JP1781851S (ja) | 薬物供給システム | |
Kaufman | Benzocaine misuse: Methaemoglobinaemia following application of benzocaine in large amounts without a prescription multiple times in a day: case report | |
TWD203321S (zh) | 輸液用泵浦之部分 | |
AR063206A1 (es) | Tratamiento del dolor |